No announcement yet.

Study raps Web sites touting stem cell therapies

  • Filter
  • Time
  • Show
Clear All
new posts

  • Study raps Web sites touting stem cell therapies

    we have to keep our eyes open, there is a good risk and a bad risk, as there is a good investment and a bad one.

    Study raps Web sites touting stem cell therapies
    By MALCOLM RITTER – 1 hour ago

    NEW YORK (AP) — Consumers should be wary of Web sites from clinics that offer stem cell treatments, says a study that found a lack of firm medical evidence to back up their claims.

    The Web sites in the study generally portrayed their therapies as safe, effective and ready for routine use, but published research doesn't support that "overoptimistic" picture, the study authors said.

    The analysis is presented in the December issue of the journal Cell Stem Cell by scientists at the University of Alberta in Canada. They cautioned that their overall findings can't be applied to the claims of any individual clinic.

    The study is "a very important wake-up call," said Dr. George Daley, past president of the International Society for Stem Cell Research, who had no role in the new report.


  • #2
    It's a little ironic that the link for this article starts with - the google ads often feature dubious clinics touting their stem cell treatments.


    • #3
      Dr. Young what do you say about those 2 articles today, is this so bad?

      Bogus Stem Cell Therapies Sold on Internet

      By Amanda Gardner
      HealthDay Reporter
      Wednesday, December 3, 2008; 12:00 AM

      WEDNESDAY, Dec. 3 (HealthDay News) -- Expensive, sham stem cell therapies are being hawked directly to desperate patients over the Internet, experts say.

      In response, the leading organization of stem cell scientists on Wednesday issued guidelines to steer research in the field toward responsible, practical uses.

      "Stem cell research is progressing so rapidly and has sparked a lot of interest in translational research [including] among patients in hopes for therapies," said Insoo Hyun, lead author of the paper outlining the guidelines and an associate professor of bioethics at Case Western Reserve University School of Medicine in Cleveland.

      "At the same time," he said, "legitimate science is speeding ahead and getting to the point where there needed to be more of a road map to take the basic knowledge to clinical applications."

      Although Hyun had not heard of patients actually been harmed by so-called stem cell therapies, he said he feared that "it's only a matter of time."

      The new guidelines were published in the December issue of Cell Stem Cell.

      Experts hailed the move.



      • #4
        Sean Hu, chairman of Beike Biotechnology, didn’t respond to the allegations leveled by the report after being reached by telephone.